Jim Simons Mirati Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $1.63 Million - $2.37 Million	-27,373 Reduced 10.2%	240,927 $16.8 Million
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $6.83 Million - $15.5 Million	174,300 Added 185.43%	268,300 $18 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $7.13 Million - $14.2 Million	94,000 New	94,000 $7.73 Million
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $5.54 Million - $7.44 Million	-41,907 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $6.91 Million - $8.63 Million	-47,993 Reduced 53.38%	41,907 $6.77 Million

Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $15 Million - $20.9 Million	-94,200 Reduced 51.17%	89,900 $15.4 Million
Q4 2020 Feb 10, 2021	BUY	$162.05 - $240.27 $29.8 Million - $44.2 Million	184,100 New	184,100 $40.4 Million
Q1 2020 May 14, 2020	SELL	$69.78 - $116.21 $4.33 Million - $7.22 Million	-62,100 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$70.76 - $128.86 $20.8 Million - $37.9 Million	-293,800 Reduced 82.55%	62,100 $8 Million
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $7.25 Million - $10.2 Million	-93,100 Reduced 20.73%	355,900 $27.7 Million
Q2 2019 Aug 12, 2019	BUY	$59.49 - $104.71 $23.7 Million - $41.7 Million	398,700 Added 792.64%	449,000 $46.2 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $497,610 - $900,030	11,400 Added 29.31%	50,300 $3.69 Million
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $1.24 Million - $1.85 Million	38,900 New	38,900 $1.65 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.